James Burke believes companies adopting ECLM solutions to automate the contract lifecycle would be well advised to understand the business problem they are trying to solve and do the diligence to see where automation makes sense and where it doesn’t for their contracting process.
Bill Martineau, MBA, believes LVPs represent one of the highest value-added applications for pharmaceutical packaging. Nonetheless, demand for IV containers will expand at a lackluster pace due to trends promoting short hospital stays and less-invasive surgeries.
Contributor Cindy H. Dubin posed a series of questions to several CDMOs to find out how they are positioned to help Pharma navigate the waters of patent expirations, rising costs, shrinking timelines, and budget constraints.
Derek G. Hennecke begins part 1 of his 6-part series on lessons learned from other industries.
Eric Resnick explains how engaging packaging manufacturers early in the process helps to ensure compliance and patient safety and enhance the overall patient experience.
Contributor Cindy H. Dubin recently spoke with some of the leading companies that offer analytical instrument equipment and services to find out how they are addressing pharma’s needs for faster (and more cost-efficient) testing.
David Underwood provides an overview of some of the significant challenges (and associated recommendations) in setting up, conducting, and reporting oncology studies.
Laszlo Fabriczi says contract management system implementations typically cause significant shifts from the manual processes in place to a more automated contracting culture; thus, an integrated approach must be taken that includes the technology and business process transformation and associated change management to fully derive significant benefits for the business.
EXCLUSIVE ONLINE CONTENT
Rentschler Biopharma & Vetter Team Up With Joint Goal to Simplify Processes & Optimize Time-To-Market
Rentschler Biopharma and Vetter recently announced their strategic collaboration to enhance their services and offer complementary….
Ajinomoto Bio-Pharma Services recently announce the launch of AJILITY, a flexible and agile drug product manufacturing platform, designed to advance….
Moderna & Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc. and Catalent, Inc. recently announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate…..
AGTC Announces Significant Productivity & Quality Enhancement to Its Proprietary Manufacturing Process
Applied Genetic Technologies Corporation recently provided an update on the continued productivity and quality improvements made in its proprietary manufacturing platform that is….
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left….